Biocon Chief Kiran Mazumdar Shaw, husband donate over Rs 51 crore to University of Glasgow

A further donation of USD 2.5 million will go towards creating a new Professorial Chair to be named the Mazumdar-Shaw Chair of Precision Oncology.

BENGALURU: Biocon founder Kiran Mazumdar-Shaw and her husband, John Shaw, have made donations worth USD 7.5 million to the University of Glasgow to contribute to expansion projects at the Scottish university.

John, a former alumnus of the university, said USD 5 million would for to the Research Hub, currently under construction on the Western Infirmary site as part of the university's 1-billion pounds campus development. The new hub will see space on a floor dedicated to public engagement named as Shaw Plaza.

A further donation of USD 2.5 million will go towards creating a new Professorial Chair to be named the Mazumdar-Shaw Chair of Precision Oncology.

Also Read: Biocon, Mylan gets Canadian nod for biosimilar of cancer drug Herceptin

"As a proud alumnus of the University of Glasgow, I have the good fortune of making a gift at a time when the university is embarking on a major expansion. Both Kiran and I have the proud privilege of being awarded honorary doctorates," said John, the Vice-Chair of Biocon.

"The success of our company, Biocon, has allowed us to be philanthropic. Research at Glasgow resonates very closely with Biocon's principal interests in diabetes and cancer. Our gift, therefore, seeks to support research and precision oncology. The University of Glasgow has the potential to advance science to new levels and become a globally-recognized research hub," he said.

Glasgow-born John's career with Scotland-based textile firm Coats included management and financial positions across the world and led to him meeting his future wife Kiran in Bangalore. When they married in 1998, her firm Biocon was a pioneering biotech venture, and John took early retirement from Coats and helped his wife transform the company from a small company into a biotech giant, the university noted in a statement.

Also Read: Biocon, Lupin, Wockhardt, Cadila Healthcare lose Insurance Battle in Delhi High Court